GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (BSP:I1QV34) » Definitions » Gross Profit

IQVIA Holdings (BSP:I1QV34) Gross Profit : R$25,956 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is IQVIA Holdings Gross Profit?

IQVIA Holdings's gross profit for the three months ended in Mar. 2024 was R$6,439 Mil. IQVIA Holdings's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was R$25,956 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. IQVIA Holdings's gross profit for the three months ended in Mar. 2024 was R$6,439 Mil. IQVIA Holdings's Revenue for the three months ended in Mar. 2024 was R$18,610 Mil. Therefore, IQVIA Holdings's Gross Margin % for the quarter that ended in Mar. 2024 was 34.60%.

IQVIA Holdings had a gross margin of 34.60% for the quarter that ended in Mar. 2024 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of IQVIA Holdings was 35.21%. The lowest was 27.49%. And the median was 34.07%.


IQVIA Holdings Gross Profit Historical Data

The historical data trend for IQVIA Holdings's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQVIA Holdings Gross Profit Chart

IQVIA Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15,547.85 19,853.40 26,244.39 26,373.87 25,670.05

IQVIA Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,531.58 6,237.01 6,469.70 6,810.72 6,438.88

Competitive Comparison of IQVIA Holdings's Gross Profit

For the Diagnostics & Research subindustry, IQVIA Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IQVIA Holdings's Gross Profit Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Gross Profit distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Gross Profit falls into.



IQVIA Holdings Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

IQVIA Holdings's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=73418.603 - 47748.551
=25,670

IQVIA Holdings's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=18609.513 - 12170.632
=6,439

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$25,956 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

IQVIA Holdings's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=6,439 / 18609.513
=34.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


IQVIA Holdings  (BSP:I1QV34) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

IQVIA Holdings had a gross margin of 34.60% for the quarter that ended in Mar. 2024 => Competition eroding margins


IQVIA Holdings Gross Profit Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


IQVIA Holdings (BSP:I1QV34) Business Description

Traded in Other Exchanges
Address
2400 Ellis Road, Durham, NC, USA, 27703
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

IQVIA Holdings (BSP:I1QV34) Headlines

No Headlines